Full Year
LITS — FY2026 Annual Financial Report Analysis
Lite Strategy (formerly MEI Pharma) lost $71.2 million in its first year as a Litecoin treasury company, most of it from a $60.1 million drop in the value of the coins bought with a $100 million share sale, leaving about $1.28 of book value per share.